The value of adriamycin and of mid-cycle treatment in multidrug therapy of unfavorable histology non-Hodgkin's lymphoma

G. J. Johnson, W. G. Costello, M. M. Oken

Research output: Contribution to journalArticlepeer-review

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)No. 793
JournalProceedings of the American Association for Cancer Research
VolumeVol. 20
StatePublished - Jan 1 1979

Cite this